Speakers

Kurt Gunter

Chief Medical Officer

Kuur Therapeutics

Sonny Hsiao

Founder & CEO

Acepodia

Stewart Abbot

CSO & COO

Adicet Bio

Sicco Popma

CEO, President & Founder

IO Biosciences

Matthias Von Herrath

VP & Senior Medical Officer, Global Chief Medical Officer

Novo Nordisk

Dario Gutierrez

VP, Discovery Research & Innovation

TCR2 Therapeutics

Rob Igarashi

VP, Discovery & Pre-clinical Development

Kiadis Pharma

Monalisa Mukherjea

Associate Director, Autologous and Allogeneic CAR-T Process Development & Manufacturing

Janssen, J&J

Tom Van Blarcom

Senior Director & Head of Protein Engineering

Allogene

Joanna Brewer

SVP, Allogeneic Research

Adaptimmune

Mark Exley

VP, Cellular Immunology

AgenTus

Mike Lehmicke

Director, Science & Industry Affairs

Alliance for Regenerative Medicine

Barbra Sasu

CSO

Allogene

Joe Newell

COO

Atara Biotherapeutics

Pascal Touchon

President & CEO

Atara Biotherapeutics

Debra Webster

Senior Director, Regulatory Affairs

BlueRock Therapeutics

Anne-Sophie Lebrun

Production & Optimisation Manager

Bone Therapeutics

Nathan Yee

Associate Director, CMC Product Strategy, Allogeneic Cell Therapy

Bristol Myers Squibb

Emilie Gauthy

R&D Manager, CMC & Process Development

Celyad Oncology

Peggy Sotiropoulou

Head of Research & Development

Celyad Oncology

Zhiqiang Wang

Assistant Research Professor

City of Hope

Tony Ho

EVP, Head of Research & Development

CRISPR Therapeutics

Olive Sturtevant

Senior Administrative Director of Connell & O’Reilly Families, Cell Manipulation Core Facility

Dana Farber Cancer Institute

Rick Morgan

SVP, Immunogenetics

Editas medicine

Greg Fiore

CEO

Exacis Biotherapeutics

Karl-Johan Malmberg

Professor

Karolinska Institute

Brian Culley

CEO

Lineage Cell Therapeutics

Elizabeth Akam

Lecturer, Biochemistry

Loughborough University

Lior Raviv

VP, Development & Operations

Pluristem

Sumiti Jain

Director, Immuno- Oncology, Cell Therapy

Poseida Therapeutics

Chris Heery

CMO

Precision Biosciences

Christina Coughlin

CMO

Rubius Therapeutics

Dan Kaufman

Professor & Director, Cell Therapy Program

UCSD

EVENT GUIDE